Insmed’s Strategic Advancements and Promising Pipeline Justify Buy Rating
Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Insmed (INSM – Research Report) yesterday and set a price target ...
Hosted on MSN2d
How Nochi Leaves Are Believed To Treat Lung Ailments
The mucus is a common symptom in chronic lung diseases such as COPD ( chronic bronchitis and emphysema), cystic fibrosis, bronchiectasis, NTM lung disease, or asthma. Besides ailments related to lungs ...
Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data
Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant ...
University of Texas at San Antonio4d
UTSA scientists are advancing treatment against infectious diseases like tuberculosis
NOVEMBER 19, 2024 — UTSA faculty are leveraging their expertise to fight Mycobacterium tuberculosis (Mtb), the germ ...
Basic research leads to drug candidates for fatal lung disease
During the 1990s, medicinal chemist Anders Hallberg was working in his lab at the Department of Medicinal Chemistry. He was exploring a hormonal system in the body that regulates blood pressure, among ...
Zinc deficiency promotes Acinetobacter lung infection, mouse study shows
Dietary zinc deficiency promotes lung infection by Acinetobacter baumannii bacteria—a leading cause of ventilator-associated ...
The Pharma Letter8d
Paratek Phase IIb results highlight omadacycline’s potential in NTM treatment
USA-based Paratek Pharmaceuticals has released positive top-line data from a Phase IIb trial evaluating its oral antibiotic ...
Yahoo Finance9d
Positive Phase II top-line data highlights omadacycline’s potential in the NTM market
In a study of 66 adult patients with nontuberculous mycobacteria pulmonary disease (NTM-PD) caused by mycobacterium abscessus ...
EurekAlert!9d
Novel SOURCE study examining development of early COPD in ages 30 to 55
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.
pulmonologyadvisor10d
MAC-PD Therapy May Be Aided by Genotypic Analysis of Pre- and On-Treatment Isolates
A fourth of patients with Mycobacterium avium complex pulmonary disease (MAC-PD) whose pre- and on-treatment isolates were the same species had genetically distinct strains within the same species in ...
Too Old to Operate11d
Combatting the Rising Rates of NTM Pulmonary Disease
Updated NTM pulmonary disease estimates in U.S. Medicare beneficiaries revealed rising incidence, demographic disparities, and associated comorbidities.